Allogene Therapeutics Inc ALLO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:04 PM EST
7.72UNCH (UNCH)
Volume
49,704
Close
7.72quote price arrow up+0.05 (+0.65%)
Volume
1,802,093
52 week range
5.41 - 17.49
Loading...
  • Open7.68
  • Day High7.93
  • Day Low7.56
  • Prev Close7.67
  • 52 Week High17.49
  • 52 Week High Date08/12/22
  • 52 Week Low5.41
  • 52 Week Low Date01/05/23

Key Stats

  • Market Cap1.113B
  • Shares Out144.21M
  • 10 Day Average Volume1.98M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change22.73

KEY STATS

  • Open7.68
  • Day High7.93
  • Day Low7.56
  • Prev Close7.67
  • 52 Week High17.49
  • 52 Week High Date08/12/22
  • 52 Week Low5.41
  • 52 Week Low Date01/05/23
  • Market Cap1.113B
  • Shares Out144.21M
  • 10 Day Average Volume1.98M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change22.73

RATIOS/PROFITABILITY

  • EPS (TTM)-2.20
  • P/E (TTM)-3.50
  • Fwd P/E (NTM)-2.75
  • EBITDA (TTM)-297.453M
  • ROE (TTM)-36.57%
  • Revenue (TTM)246,999.994
  • Gross Margin (TTM)-
  • Net Margin (TTM)-126,580.20%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/21/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Allogene Therapeutics Inc

Profile

MORE
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. It is engaged in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein engineering, gene editing, gene insertion and advanced T cell manufacturing technologies. Its advanced product candidates...
Arie Belldegrun M.D.
Executive Chairman of the Board
David Chang M.D., Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Eric Schmidt Ph.D.
Chief Financial Officer
Alison Moore Ph.D.
Chief Technical Officer
Address
210 E Grand Ave
South San Francisco, CA
94080-4811
United States

Top Peers

SYMBOLLASTCHG%CHG
SAVA
Cassava Sciences Inc
28.00+0.76+2.79%
CRNX
Crinetics Pharmaceuticals Inc
19.61+0.51+2.67%
DICE
Dice Therapeutics Inc
31.77-0.35-1.09%
INBX
Inhibrx Inc
25.00-0.13-0.52%
ACRS
Aclaris Therapeutics Inc
16.90+0.05+0.30%